OUTSET MEDICAL INC (OM) Fundamental Analysis & Valuation

NASDAQ:OM • US6901452069

3.17 USD
-0.09 (-2.76%)
Last: Mar 12, 2026, 10:36 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This OM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to OM. OM was compared to 184 industry peers in the Health Care Equipment & Supplies industry. While OM seems to be doing ok healthwise, there are quite some concerns on its profitability. OM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. OM Profitability Analysis

1.1 Basic Checks

  • OM had negative earnings in the past year.
  • OM had a negative operating cash flow in the past year.
  • In the past 5 years OM always reported negative net income.
  • In the past 5 years OM always reported negative operating cash flow.
OM Yearly Net Income VS EBIT VS OCF VS FCFOM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

  • OM's Return On Assets of -30.87% is in line compared to the rest of the industry. OM outperforms 41.30% of its industry peers.
  • OM has a Return On Equity of -64.32%. This is comparable to the rest of the industry: OM outperforms 45.11% of its industry peers.
Industry RankSector Rank
ROA -30.87%
ROE -64.32%
ROIC N/A
ROA(3y)-44.11%
ROA(5y)-40.31%
ROE(3y)-227.37%
ROE(5y)-156.73%
ROIC(3y)N/A
ROIC(5y)N/A
OM Yearly ROA, ROE, ROICOM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • The Gross Margin of OM (39.13%) is worse than 69.02% of its industry peers.
  • In the last couple of years the Gross Margin of OM has grown nicely.
  • The Profit Margin and Operating Margin are not available for OM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.39%
GM growth 5YN/A
OM Yearly Profit, Operating, Gross MarginsOM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. OM Health Analysis

2.1 Basic Checks

  • OM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OM has been reduced compared to 1 year ago.
  • The number of shares outstanding for OM has been reduced compared to 5 years ago.
  • Compared to 1 year ago, OM has an improved debt to assets ratio.
OM Yearly Shares OutstandingOM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
OM Yearly Total Debt VS Total AssetsOM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • OM has an Altman-Z score of -5.36. This is a bad value and indicates that OM is not financially healthy and even has some risk of bankruptcy.
  • OM has a worse Altman-Z score (-5.36) than 72.28% of its industry peers.
  • OM has a Debt/Equity ratio of 0.76. This is a neutral value indicating OM is somewhat dependend on debt financing.
  • OM's Debt to Equity ratio of 0.76 is on the low side compared to the rest of the industry. OM is outperformed by 69.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z -5.36
ROIC/WACCN/A
WACC7.34%
OM Yearly LT Debt VS Equity VS FCFOM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 6.67 indicates that OM has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 6.67, OM belongs to the top of the industry, outperforming 84.78% of the companies in the same industry.
  • A Quick Ratio of 5.40 indicates that OM has no problem at all paying its short term obligations.
  • OM's Quick ratio of 5.40 is amongst the best of the industry. OM outperforms 82.07% of its industry peers.
Industry RankSector Rank
Current Ratio 6.67
Quick Ratio 5.4
OM Yearly Current Assets VS Current LiabilitesOM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. OM Growth Analysis

3.1 Past

  • OM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.22%, which is quite impressive.
  • Looking at the last year, OM shows a small growth in Revenue. The Revenue has grown by 5.09% in the last year.
  • The Revenue has been growing by 19.08% on average over the past years. This is quite good.
EPS 1Y (TTM)79.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.86%
Revenue 1Y (TTM)5.09%
Revenue growth 3Y1.16%
Revenue growth 5Y19.08%
Sales Q2Q%-2.01%

3.2 Future

  • OM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.00% yearly.
  • OM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.56% yearly.
EPS Next Y51.21%
EPS Next 2Y24.87%
EPS Next 3Y20.47%
EPS Next 5Y15%
Revenue Next Year7.99%
Revenue Next 2Y9.58%
Revenue Next 3Y11.01%
Revenue Next 5Y11.56%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OM Yearly Revenue VS EstimatesOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
OM Yearly EPS VS EstimatesOM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40 -60 -80

More info and screens

Find the best growth stocksShow best growing peers

1

4. OM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OM. In the last year negative earnings were reported.
  • Also next year OM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OM Price Earnings VS Forward Price EarningsOM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OM Per share dataOM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

  • OM's earnings are expected to grow with 20.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.87%
EPS Next 3Y20.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OM Dividend Analysis

5.1 Amount

  • No dividends for OM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OM Fundamentals: All Metrics, Ratios and Statistics

OUTSET MEDICAL INC

NASDAQ:OM (3/12/2026, 10:36:26 AM)

3.17

-0.09 (-2.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners94.44%
Inst Owner Change-13.5%
Ins Owners1.86%
Ins Owner Change-1.84%
Market Cap57.54M
Revenue(TTM)119.48M
Net Income(TTM)-81.65M
Analysts83.08
Price Target10.71 (237.85%)
Short Float %13.15%
Short Ratio2.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.1%
Min EPS beat(2)-27.93%
Max EPS beat(2)-2.28%
EPS beat(4)1
Avg EPS beat(4)-61.52%
Min EPS beat(4)-232.87%
Max EPS beat(4)16.99%
EPS beat(8)3
Avg EPS beat(8)-28.11%
EPS beat(12)4
Avg EPS beat(12)-21.15%
EPS beat(16)5
Avg EPS beat(16)-17.87%
Revenue beat(2)1
Avg Revenue beat(2)-1.14%
Min Revenue beat(2)-7.47%
Max Revenue beat(2)5.19%
Revenue beat(4)3
Avg Revenue beat(4)1.33%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)5.19%
Revenue beat(8)5
Avg Revenue beat(8)-1.92%
Revenue beat(12)7
Avg Revenue beat(12)-1.51%
Revenue beat(16)9
Avg Revenue beat(16)-1.48%
PT rev (1m)-10.64%
PT rev (3m)-33.33%
EPS NQ rev (1m)1.87%
EPS NQ rev (3m)1.87%
EPS NY rev (1m)0%
EPS NY rev (3m)0.09%
Revenue NQ rev (1m)-1.51%
Revenue NQ rev (3m)-1.39%
Revenue NY rev (1m)-0.81%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B 0.45
P/tB 0.45
EV/EBITDA N/A
EPS(TTM)-5.61
EYN/A
EPS(NY)-2.74
Fwd EYN/A
FCF(TTM)-2.6
FCFYN/A
OCF(TTM)-2.55
OCFYN/A
SpS6.58
BVpS6.99
TBVpS6.99
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.87%
ROE -64.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.13%
FCFM N/A
ROA(3y)-44.11%
ROA(5y)-40.31%
ROE(3y)-227.37%
ROE(5y)-156.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.39%
GM growth 5YN/A
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.38%
Cap/Sales 0.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.67
Quick Ratio 5.4
Altman-Z -5.36
F-Score6
WACC7.34%
ROIC/WACCN/A
Cap/Depr(3y)31.17%
Cap/Depr(5y)62.98%
Cap/Sales(3y)1.37%
Cap/Sales(5y)2.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.86%
EPS Next Y51.21%
EPS Next 2Y24.87%
EPS Next 3Y20.47%
EPS Next 5Y15%
Revenue 1Y (TTM)5.09%
Revenue growth 3Y1.16%
Revenue growth 5Y19.08%
Sales Q2Q%-2.01%
Revenue Next Year7.99%
Revenue Next 2Y9.58%
Revenue Next 3Y11.01%
Revenue Next 5Y11.56%
EBIT growth 1Y41.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4.12%
EBIT Next 3Y15.83%
EBIT Next 5Y17.24%
FCF growth 1Y59.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.17%
OCF growth 3YN/A
OCF growth 5YN/A

OUTSET MEDICAL INC / OM FAQ

What is the fundamental rating for OM stock?

ChartMill assigns a fundamental rating of 3 / 10 to OM.


Can you provide the valuation status for OUTSET MEDICAL INC?

ChartMill assigns a valuation rating of 1 / 10 to OUTSET MEDICAL INC (OM). This can be considered as Overvalued.


How profitable is OUTSET MEDICAL INC (OM) stock?

OUTSET MEDICAL INC (OM) has a profitability rating of 1 / 10.


How financially healthy is OUTSET MEDICAL INC?

The financial health rating of OUTSET MEDICAL INC (OM) is 5 / 10.